Walgreens: at the corner of HAPPY & HEALTHY

Walgreens apologizes after failing to notify parents of canceled child vaccine appointments

https://www.washingtonpost.com/business/2021/12/05/walgreens-cancels-vaccine-appointments/

The drug store chain declined to say how many families were turned away but said it is working to fix its system

Dania Palanker and her 7-year-old daughter, Nadia, felt excited as they bundled into the car in Washington last week to get Nadia’s coronavirus vaccine.

The evening before, Palanker received an automated email from Walgreens confirming Nadia’s appointment at the chain’s outlet in Cheverly, Md. “We’ll see you tomorrow!” read the subject line.

Their anticipation turned to disappointment once they arrived for the 6:30 p.m. shot. The store was still open, but the pharmacists had left, the pharmacy counter was closed and no one could provide vaccines. The pharmacy shuttered a half-hour before Nadia’s confirmed appointment, part of service cutbacks by Walgreens caused by a labor shortage hitting drugstores across the country.

“She was stoic,” Palanker said of her daughter. “I was furious.” Later that evening, she said, Nadia “looked close to tears.” Palanker went back online and found a city-run District of Columbia walk-up vaccination site, where Nadia got her shot the next day.

Walgreens apologized to affected customers in an email to The Washington Post and said it was working to prevent such problems moving forward. The company would not say how many of its customers nationwide have suffered the same frustration. Similar tales from angry consumers have popped up on social media around the country since early November.

The problems arose as demand is surging for coronavirus vaccine boosters as well as pediatric vaccine doses. President Biden’s administration has authorized boosters for everyone over 18 and is urging everyone to get the additional shot in response to the spread of the new omicron variant.

Palanker, a research professor and specialist on insurance and health care access at Georgetown’s Health Policy Institute, said she was especially dismayed because of the broader implications of her experience. An unannounced vaccine cancellation for a child would have a bigger impact on a family with less work flexibility or longer driving distances.

“My whole takeaway is Walgreens really dropped the ball,” Palanker said.

Walgreens is not alone among national chain pharmacies suffering from staff shortages. CVS said in September it was hiring 25,000 new workers at its stores, most of them pharmacists, pharmacy techs and nurses, to respond to heavy demand for coronavirus and flu vaccines and coronavirus tests.

But unlike rivals CVS and Rite Aid, Walgreens is attracting social media complaints from consumers about child vaccine appointments canceled without notice. Customers with appointments for booster shots and coronavirus tests also have complained on Twitter in recent days that they showed up to find closed Walgreens pharmacies.

Walgreens said it is working to improve its digital notification system to keeps up with local cuts in pharmacy service.

“We take this feedback seriously and are enhancing our digital scheduler to ensure it better supports fluctuations in store hours,” Walgreens spokeswoman Kelli Teno said in an email. “We apologize for any inconvenience to our customers and patients.”

Pharmacy operators have encountered the same pandemic-related workforce shortages as other health care providers and businesses, from retail stores to restaurants, said Scott Knoer, chief executive of the American Pharmacists Association, a professional education and advocacy organization based in Washington, D.C.

At the same time, demand for coronavirus testing and vaccines has increased the reliance on drugstores in the battle against the pandemic, he said.

“Pharmacists are having a tremendous amount of burnout right now,” he said.

As of Nov. 9, more than 162.8 million coronavirus vaccine doses have been administered by retail pharmacies in the United States, or about a third of all shots, according to the Centers for Disease Control and Prevention.

A shortage of pharmacists in the 1990s led to wage growth, but in more recent years there has been an oversupply, Knoer said. Then coronavirus suddenly boosted demand way beyond supply, sending chains into a struggle to fill jobs. ZipRecruiter and Glassdoor say pharmacists are paid between $100,000 and $150,000 a year. Walgreens in September announced bonuses of $1,250 for full-time pharmacists.

After the Food and Drug Administration on Oct. 29 authorized Pfizer coronavirus vaccine for children ages 5 through 11, the conflict between heavy demand from parents and surprise pharmacy closures created friction.

Anthony Funari, a grant professional and English professor at a community college in the Kansas City suburbs, had a confirmed vaccine appointment at a Walgreens in Olathe, Kan., for his sons, Will and Gabriel, on Nov. 11. He and his wife took time off from work and pulled the boys out of school shortly before their 10 a.m. appointments. The evening before, they had received the same cheerful appointment confirmation as Palanker.

“We were incredibly excited. This was the end of the pandemic for us in a way. We’d always been worried about our boys coming down with covid,” said Funari, whose story was first reported in the Kansas City Star in mid-November. When they arrived and learned from a store manager that the pharmacy was closed, Funari said he felt “disappointment, shock, frustration, anger.” His mother in law found a community pharmacy that could provide the shots later that day, he said.

In Homer, N.Y., Julie McChesney took her 10-year-old son, Zach, to his scheduled appointment at a Walgreens that was 25 minutes away from their home for a second vaccine shot. It was the Saturday after Thanksgiving. Once she found the pharmacy closed for the entire weekend, she and her son retreated to a Dunkin’ across the street, got some hot chocolate and hunted down another shot at a different Walgreens for later that day.

“I do wish somebody had let me know beforehand,” she said. “It would have been the right thing to do.”

Walgreens said it expects conditions to improve moving forward.

“We expect to resolve this quickly as we update the scheduler to accommodate fluctuating store hours and more appointments open up,” Teno said. “Beginning this Saturday, Dec. 4, we have 50% vaccine appointment capacity across all of our stores. The following week, Dec. 11, we have even more capacity, with nearly 70% of appointments available.”

One of: American Pain and Disability Foundation advocate

 

pharmacist steve blog reaches 2,500,000 page views !

When an adult buys a “Percocet” from a friend of a friend, should anyone be surprised when they die from a lethal overdose ?

https://youtu.be/G7Gjd4kQT1E?t=1135

This is a very interesting episode of Judge Jeanine on her weekly Saturday night show. Considering that Jeanine is an attorney and former judge… she is bringing on a woman who mid-20’s daughter got some “Percocet” from a friend of a friend because the Daughter had hurt back and the Daughter died, because the “Percocet” contained illegal fentanyl.  Judge Jeanine’s entire episode was about the availability of illegal fentanyl…  Nothing about the Daughter or the friend of a friend was violating the  controlled substance act…  was the friend of a friend a “drug dealer” ? That was 2015 and now this Mother has a non profit with some 23,000 members wanting illegal fentanyl to not get into the country.

In this episode, they seem to be using the word “poisoning” instead of the word “over dose”  I guess that a pt that ends his pain via prescriber induced suicide is of no interest to Fox cable … even when the local Fox TV in Louisville,KY… the only station – out of FOUR – in Louisville did a story when the case was filed and when the case was settled.  Prescriber induced suicide- jury awards a SEVEN MILLION JUDGEMENT

Nor when a CHILD is forced to endure debridement from 3rd degree burns for SIX WEEKS WITHOUT ANY PAIN MANAGEMENT Vanderbilt Burn Center (Nashville) refused to provide the young patient sufficient pain medication for SIX WEEKS

 

Ire over pharmacy middlemen fuels lobbying blitz

Ire over pharmacy middlemen fuels lobbying blitz

The effort to paint pharmacy benefit managers as villains has sparked a multimillion-dollar campaign to influence Democrats.

https://www.politico.com/news/2021/12/04/pharmacy-lobbyists-social-spending-bill-523749

Prescription pills are shown.

Lobbyists for drugmakers, pharmacists and large employers are blanketing Congress with calls, emails and advertisements, pressing lawmakers to rein in pharmaceutical middlemen, who they say are behind soaring drug costs.

The effort to paint pharmacy benefit managers as villains has sparked a multimillion-dollar campaign to influence Democrats, who are racing to finish their massive social spending bill and eager to show they are taking on the powerful drug industry and lowering out-of-pocket costs for Americans.

“Pretty much everyone in the supply chain is pointing at the PBMs right now,” said Karry La Violette, the senior vice president of government affairs at the National Community Pharmacists Association.

While there is little agreement among PBM opponents about what actions Congress should take, industry lobbyists are offering a menu of options for Democrats to consider, such as requiring PBMs to pass on more of the rebates they negotiate with drugmakers to consumers or employers. They could also ban a common practice called spread pricing in which PBMs charge health plans more than they pay to the pharmacy dispensing a drug, and pocket the difference.

PBMs have responded with their own lobbying and advertising blitz, and insist they’re being scapegoated. JC Scott, who leads the Pharmaceutical Care Management Association, the trade group for PBMs, said targeting his members might be good politics and take the focus off drugmakers during a critical moment in the debate, but it would not lower drug costs.

Although dozens of PBMs exist, the industry is consolidated, with three of them — CVS Caremark, Express Scripts and OptumRx — controlling nearly 80 percent of the prescription market. Health insurers, employers and government hire PBMs to manage prescription benefits for their health plans — putting them at the center of a supply chain consisting of drugmakers, insurers and pharmacies.

Critics allege that PBMs’ role in negotiating rebates from pharmaceutical manufacturers and developing lists of prescription drugs that health insurers will cover encourages them to prioritize higher-cost medicines where they can reap larger rebates rather than focusing on drugs with lower costs.

“Democrats are focused on lowering costs for patients — and that absolutely includes making sure pharmacy benefit managers are getting the best deal for patients not for themselves,” Sen. Patty Murray (D-Wa.) said in a statement.

The $1.7 trillion spending bill, which the House passed last month, includes provisions that require PBMs to disclose certain information to employer-based plans, aiming to help them negotiate better prices for drugs, but other industry lobbyists want Democrats to go much further, which could make Senate passage that much more complicated.

Independent pharmacists and their patients have sent Congress thousands of letters at the behest of the National Community Pharmacists Association, which in the coming days will unleash its own television ad campaign urging senators to rein in PBMs.

On Friday, the pharmaceutical industry launched a seven-figure national ad campaign urging lawmakers to compel PBMs to pass rebates directly to consumers at the pharmacy counter. Called point-of-sale rebates, PBMs and others argue that this would ultimately raise premiums.

“There is recognition on both sides of the aisle that PBMs play a significant role in a broken insurance system, but somehow a bill meant to lower drug costs does nothing to address the part these middlemen play in determining what patients pay out of pocket for medicines,” said Sarah Sutton, a spokesperson for the Pharmaceutical Research and Manufacturers of America (PhRMA), which is running ads on television, radio and the Internet.

She would not reveal the price tag of the new ad spending, but PhRMA spent more than $2.5 million in its television ad buys during the summer opposing liberal efforts to have Medicare negotiate the price of drugs, according to AdAnalytics data analyzed by POLITICO. And the group spent upwards of $22 million on lobbying in the first nine months of 2021, a 10 percent increase from the same period in 2020.

While pharmaceutical companies were the main target of Democrats’ efforts to reduce the cost of drugs, PBMs, which spent $5.9 million on lobbying in the first nine months of this year, a 20 percent increase over the same period in 2020, emerged largely unscathed in the House version.

Although the PBM industry still has concerns about transparency provisions, it successfully stopped Democrats from including a ban on spread pricing. The industry also supported a repeal of the Trump administration’s so-called rebate rule, which made it into the House’s version of the bill.

That’s forced lobbyists for drugmakers, pharmacies and employer groups to take their case to the Senate, where Sen. Ron Wyden (D-Ore.), the chair of the Senate Finance Committee, has already expressed interest in more closely scrutinizing the role PBMs play in the reconciliation package.

“Chairman Wyden is the champion on this issue,” said James Gelfand, the executive vice president of public affairs at the ERISA Industry Committee, which represents the employee benefits interests of the nation’s largest employers. “So it’d be crazy to think that he’s not right now considering, ‘What else can I do in this space?’”

“It’s the legislative opportunity of the century,” he added. “You don’t just give that up, right?”

In a statement to POLITICO, Wyden said that pharmacy benefit managers “are taking advantage of this dysfunctional system while families and local pharmacies foot the bill,” adding, “the status quo when it comes to PBMs needs to change as much as it does for Big Pharma.”

Scott, the PCMA leader, says his industry is being unfairly maligned for two reasons: an attempt to get long-desired policies enacted through the massive spending bill that have nothing to do with drug costs, and misplaced anger at the industry.

“There is this sentiment around some stakeholders that they believe, ‘Well, gee, if one part of the drug supply chain is going to be impacted by this legislation, then the PBM industry needs to give its pound of flesh as well,’” he said. “And I don’t know that that’s a very thoughtful consideration to put into policy decisions.”

The group launched its own ad campaign last week, accusing its rivals of trying to shift the blame for rising drug prices.

“Ironically, the industry that controls the list price of prescription drugs has attempted to point the finger at those focused on reducing the cost of prescription drugs for patients and payers,” reads text from the digital campaign, which is targeted within the Beltway.

But Gelfand, of the employer group, said that continuing with the status quo is untenable for patients.

“Everybody involved in all this knows that the current system is completely unsustainable,” Gelfand said. “There are those trying to change it and then there are those trying to essentially get what they can out of it while they can.”

DEA: causing 100 pts/day to be intentionally thrown into cold turkey withdrawal

Crestview Hills , KY  had a estimate population of 3300, but on the map it appears that it could be one of several  bedroom communities to Cincinnati, Ohio, so it would appear not unexpected that this clinic had 3000 pts.  Ohio has never been known as a chronic pain friendly state, but the state has been a part of the “so called” opiate crisis.  Just imagine, in the greater Cincinnati Ohio, 100 pts a day going into cold turkey withdrawal.  At the hand of the DEA … we all saw what Prosecutorial Misconduct looked like in Kyle Rittenhouse Trial.  https://www.paulcraigroberts.org/2021/11/09/prosecutorial-misconduct-in-kyle-rittenhouse-trial-exposed/

Who would not believe that federal prosecutors are capable of doing similar things to get fabricated charges against prescribers.

Typical process for the DEA raiding a prescriber’s office is to confiscate the pts’ medical records and ignore requests by the pts to get copies of their medical records.  Thus no other prescriber will take them into their practice because they have no medical history and/or many prescribers will just REFUSE to accept any pt from a “RAIDED PRACTICE”… because they MAY BE a “troublesome pt.”

How many suicides can we expect, if these two pain prescribers lose their DEA license ? Could it be labeled as a “bureaucratic genocide” or “bureaucratic induced suicide” ?  I am sure that the DEA will label any/all bad pt outcomes as “collateral damage”

3,000 NKY patients could be forced to find new care due to federal opioid accusations

https://www.wcpo.com/news/region-northern-kentucky/3-000-nky-patients-could-be-forced-to-find-new-care-due-to-federal-opioid-accusations

CRESTVIEW HILLS, Ky. — More than 3,000 patients could be forced to find new medical care after two well-known doctors in Northern Kentucky face federal charges, accused of writing illegitimate prescriptions for controlled substances.

On Nov. 18, a federal grand jury indicted Dr. Kendall Hansen and Dr. Michael Fletcher in two separate cases. The pair are listed as practicing at Interventional Pain Specialists in Crestview Hills, Ky.

Federal agents accuse Hansen of getting other doctors to prescribe him high doses of opioids. Those agents claim Hansen would write prescriptions for employees and instruct them to bring him the pills.

The indictment against Hansen lists 480 tramadol doses and 30 phentermine doses.

In a separate filing, federal agents accuse Fletcher of writing oxycodone hydrochloride prescriptions that were not for legitimate medical use.

The Kentucky Board of Medical Licensure restricted both Fletcher and Hansen’s licenses Nov. 23, prohibiting them from prescribing controlled substances.

Each doctor had federal arraignments Dec. 1 in which they pleaded not guilty. Hansen wrote a statement to WCPO 9 saying the federal court decided he could continue to prescribe controlled medications pending the result of his case.

“We are worried about public safety and welfare if over 100 patients a day……are forced to go into withdrawal

… and then feel the full effect of their pain and lose the ability to function because of their medically necessary pain diagnosis,” Hansen said in the statement. “We have over 3,000 patients, so this could result in a medical emergency and national news.”

Hansen said there are a few other local pain practices, but not enough to take on all of their patients. Hansen says Interventional Pain Specialists has been under investigation for about three years, and no charges have been filed against the business.

Outside the practice, one of Hansen’s patients, Jacqueline Fritsch, said, “When I came here, I could hardly walk, and that man has helped me tremendously. I can walk now.”

One of Fletcher’s patients, Jackie Carter, cried as she described the pain she is enduring since the federal indictment.

“On top of all the pain, I’m having withdrawal symptoms,” said Carter. “This is not right. There’s people that’s in extreme pain, myself included, and what he’s done is just not acceptable.”

Carter said she has had trouble finding other care.

“I have tried, but I have been told by eight doctors this morning doctor’s offices say they will not touch Dr. Fletcher’s patients.

They will not see them. They said to check with your primary physician,” said Carter.

She said her primary doctor does not prescribe controlled substances, an issue Hansen raised in his statement.

“IPS and the Specialty of Pain Management was asked to increase prescribing of opioids after primary care physicians were told to limit chronic prescribing,” Hansen said. “I have been in discussions with heads of St. Elizabeth Hospitals asking for help during our recent issue.”

Hansen filed a complaint in federal court in August against CVS Pharmacy. In it, he accuses pharmacists of refusing to fill his patients’ prescriptions.

WCPO 9 is still waiting for a response from Fletcher.

He faces three counts of Distribution of a Controlled Substance. Hansen faces one count of Conspiracy to Distribute Controlled Substance and two counts of Distribution of a Controlled Substance.

They are each scheduled to be back in court for pretrial conferences Jan. 26.

Trump And The GE Parses Kolodny’s Opioid Hoax December 2nd At 7PM

Trump And The GE Parses Kolodny’s Opioid Hoax December 2nd At 7PM

https://newyorkshockexchange.com/2021/11/26/trump-and-the-ge-parses-kolodnys-opioid-hoax-december-2nd-at-7pm/

The opioid epidemic has dominated the 24-hour news cycle for the past four years. Drug overdose deaths have surpassed car accidents pursuant to accidental deaths. Drug overdose deaths were exacerbated by a spike in opioid-relate drug overdoses. Fentanyl has been so prevalent in overdose deaths that the CDC started tracking fentanyl-related drug overdoses separately. The prevailing theory was (1) the spike in opioid prescriptions coincided with runaway overdose deaths so (2) cutting prescriptions would sharply reduce drug overdose deaths.

That said, Andrew Kolodny has made a big name for himself, fueling the flames against prescription opioids. Mr. Kolodny appeared on HBO’s The Crime of the Century pursuant to Purdue Pharma’s role in the opioid crisis. I was initially impressed with Kolodny. He seemed extremely passionate and convincing. However, as more data on drug overdose deaths emerged and after I spoke with people familiar with drug users, Kolodny’s narrative began to crack. Below is a 2020 tweet quoting Kolodny, and implying the opioid epidemic was driven by the masses becoming addicted to prescription opioids.

Recent data suggests something totally different. Drug overdose deaths for the trailing 12 months through April 2021 exceeded 100,000, a Y/Y rise of nearly 29%. About two-thirds (64%) of all drug overdose deaths was related to synthetic opioids (primarily fentanyl), up from 49% in the year-earlier period. This implies drug overdoses deaths related to synthetic opioid rose about 68% Y/Y. This is despite the fact that prescription opioid volume is expected to drop for the ninth consecutive year — a decline of 60% from its peak in 2011. If opioid prescriptions are declining then why do drug overdose deaths (and opioid-related drug overdose deaths) continue to rise? The data suggests that (1) illicit fentanyl and (2) drug addicts who use heroin or heroin laced with fentanyl are driving the spike in drug overdose deaths.

Kolodny recently spoke with Axios about the record drug overdose deaths. Below is an excerpt from part of that video. The interview was so patently absurd that it bordered on make-believe:

Niala Boodhoo: How much of this is about opioid overdoses specifically?

Kolodny: The vast majority of these drug overdose deaths are opioid. In particular, they involve an illicitly synthesized opioid called fentanyl.

Niala Boodhoo: Were you expecting the numbers to be so high at this point?

Kolodny: Opioid overdose deaths have been skyrocketing for the past few years, and actually for more than past 25 years, each year we’ve been setting a record for death from drug overdoses, and then the next year we break that record. But the last few years have been the worst. I expected the numbers to continue to get worse, but not this bad.

Niala Boodhoo: How much did the pandemic exacerbate this?

Kolodny: It’s difficult to say, but there are reasons to believe that COVID did make the problem worse.

The problem is that Kolodny, state attorneys general (who are suing opioid manufacturers), trial lawyers (who are earning billions in legal fees), Dopesick (Hulu), The Pharmacist (Netflix) and the fake news have been driving the narrative. I understand that Kolodny served as a consultant to some of the plaintiffs pursuant to fake opioid lawsuits. Judges in California and Oklahoma recently “called cap,” and ruled that opioid manufacturers were not liable for the opioid crisis. It is time for those in the know to set the record straight about what is really driving drug overdose deaths.

On Thursday December 2nd at 7PM (NYC time), Trump And The GE will parse through Kolodny’s interview with facts and real-world data. We are asking doctors, drug users, pain patients, researchers and concerned citizens to participate. There is a groundswell of activists and patients interested in this issue. Trump And The GE would like to provide a forum for each person’s voice to be heard.

Access The Show

You are more than welcome to participate as an audience member and ask questions during the event. The platform is similar to Zoom. The audience can access the show via Google Chrome by clicking the following link —> https://riverside.fm/studio/trump-and-the-ge-parse-kolodnys-opioid-hoax

The FDA has narrowly backed Merck’s covid pill—but it’s not that effective

The FDA has narrowly backed Merck’s covid pill—but it’s not that effective

https://www.technologyreview.com/2021/12/01/1040776/the-fda-has-narrowly-backed-mercks-covid-pill-but-its-not-that-effective/

The news: A US Food and Drug Administration panel has voted by 13 to 10 to recommend that the government authorize Merck’s antiviral pill for patients with early covid-19 who are at high risk for severe infection. The drug, called molnupiravir, has been shown to reduce the risk of hospitalization and death, although by less than previously thought. Initial results in October found it cut the risk of hospitalization or death by 50% when given to 755 unvaccinated volunteers who were mildly to moderately ill with covid-19 and had at least one risk factor for severe illness. Last week, with updated data from 1,433 patients, that figure was cut to 30%. “The efficacy of this product is not overwhelmingly good,” said panel member David Hardy.

Lacking consensus: The closeness of the vote was due to concerns over the change in the drug’s efficacy data, but also over its safety. James Hildreth, CEO of Meharry Medical College and one of the panel members, said he voted no because he worried that the use of molnupiravir could, theoretically, lead to new covid-19 variants. Other panelists, though, argued that the overall risk was small enough to vote it through. 

Who can take it: If it’s authorized, the drug will be prescribed to high-risk people who have begun experiencing symptoms to take twice a day at home for five days. Tens of millions of Americans who are older or have underlying medical conditions would qualify, and they’d need to begin taking it within five days of symptoms appearing. The committee recommended tight restrictions on molnupiravir’s use in pregnant women, given concerns about the potential side effects. 

What’s next: In the coming weeks, the FDA will assess a similar pill from Pfizer that seems to be significantly more effective than Merck’s, reducing the risk of hospitalization or death within the same patient groups by 89%. The hope is that these drugs could provide promising new weapons in our arsenal against covid, especially because they are easily stored and can be taken at home. The US government has already spent billions of dollars to secure large supplies of both new pills. 

Pfizer COVID Vaccine Antibodies May Disappear in 7 Months, Study Says

Pfizer COVID Vaccine Antibodies May Disappear in 7 Months, Study Says

https://www.medscape.com/viewarticle/960214

Antibody levels may wane after 7 months for people who got the Pfizer-BioNTech vaccine, according to a new study published on the bioRxiv preprint server.

In the study, which hasn’t yet been peer-reviewed or formally published in a medical journal, researchers analyzed blood samples from 46 healthy young or middle-aged adults after receiving two doses, and then 6 months after the second dose.

“Our study shows vaccination with the Pfizer-BioNTech vaccine induces high levels of neutralizing antibodies against the original vaccine strain, but these levels drop by nearly 10-fold by 7 months,” the researchers told Reuters.

In about half of the adults, neutralizing antibodies were undetectable at 6 months after the second dose, particularly against coronavirus variants such as Delta, Beta, and Mu.

Neutralizing antibodies only make up part of the body’s immune defense against the virus, Reuters noted, but they are still “critically important” in protecting against coronavirus infections.

“These findings suggest that administering a booster dose at around 6 to 7 months following the initial immunization will likely enhance protection,” the study authors wrote.

BioNTech said a new vaccine formula will likely be needed by mid-2022 to protect against future mutations of the virus, according to the Financial Times.

“This year, [a different vaccine] is completely unneeded, but by mid-next year, it could be a different situation,” Ugur Sahin, MD, co-founder and CEO of BioNTech, told the news outlet.

Current variants, namely the Delta variant, are more contagious than the original coronavirus strain but not different enough to evade current vaccines, he said. But new strains may be able to evade boosters.

“This virus will stay, and the virus will further adapt,” Sahin said. “This is a continuous evolution, and that evolution has just started.”

If you want to share your #PatientStory please send to NationalPainCouncil.org.

https://www.linkedin.com/posts/jonelle-elgaway-86923315a_ama-patientstory-wer1-activity-6871571377493688320-gqRy